Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients

NCT00440622 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

90

Enrollment

OTHER

Sponsor class

Stopped Due to poor accrual

Conditions

Breast Cancer

Interventions

DRUG: Gemcitabine
DRUG: Herceptin
DRUG: Capecitabine (Xeloda)

Sponsor

Hellenic Oncology Research Group

Collaborators

[object Object]